RedHill Biopharma Ltd. (RDHL)
0.6498
+0.02
(+3.14%)
USD |
NASDAQ |
Aug 28, 11:12
RedHill Biopharma Max Drawdown (5Y) : 99.99% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.99% |
| June 30, 2026 | 99.99% |
| May 31, 2026 | 99.99% |
| April 30, 2026 | 99.99% |
| March 31, 2026 | 99.99% |
| February 28, 2026 | 99.99% |
| January 31, 2026 | 99.99% |
| December 31, 2025 | 99.99% |
| November 30, 2025 | 99.99% |
| October 31, 2025 | 99.99% |
| September 30, 2025 | 99.99% |
| August 31, 2025 | 99.99% |
| July 31, 2025 | 99.99% |
| June 30, 2025 | 99.98% |
| May 31, 2025 | 99.98% |
| April 30, 2025 | 99.98% |
| March 31, 2025 | 99.98% |
| February 28, 2025 | 99.97% |
| January 31, 2025 | 99.95% |
| December 31, 2024 | 99.94% |
| November 30, 2024 | 99.94% |
| October 31, 2024 | 99.94% |
| September 30, 2024 | 99.94% |
| August 31, 2024 | 99.94% |
| July 31, 2024 | 99.93% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.93% |
| May 31, 2024 | 99.93% |
| April 30, 2024 | 99.93% |
| March 31, 2024 | 99.93% |
| February 29, 2024 | 99.93% |
| January 31, 2024 | 99.93% |
| December 31, 2023 | 99.93% |
| November 30, 2023 | 99.93% |
| October 31, 2023 | 99.93% |
| September 30, 2023 | 99.89% |
| August 31, 2023 | 99.82% |
| July 31, 2023 | 99.74% |
| June 30, 2023 | 99.74% |
| May 31, 2023 | 99.54% |
| April 30, 2023 | 99.50% |
| March 31, 2023 | 99.10% |
| February 28, 2023 | 98.79% |
| January 31, 2023 | 98.79% |
| December 31, 2022 | 98.79% |
| November 30, 2022 | 96.90% |
| October 31, 2022 | 95.91% |
| September 30, 2022 | 95.70% |
| August 31, 2022 | 94.45% |
| July 31, 2022 | 94.45% |
| June 30, 2022 | 94.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 82.42% |
| MediWound Ltd. | 84.69% |
| Purple Biotech Ltd. | 99.88% |
| Sol-Gel Technologies Ltd. | 97.87% |
| PolyPid Ltd. | 99.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -133.80 |
| Beta (5Y) | 5.000 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 171.6% |
| Historical Sharpe Ratio (5Y) | -0.5115 |
| Historical Sortino (5Y) | -1.507 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 52.81% |